serplulimab
fosun pharmaceuticals
['serplulimab', 'sclc']
astrum 002: serplulimab in extended sclc.
the drug loook interesting with higher outcome than usual with anti-pd(l)1: mos 15mo vs. 10 (hr 0,63); mpfs 5,7mo vs. 4,3mo (hr 0,48). however, this drug should have been compared to labelled io in this setting. #asco22 
Head of pulmonology unit @pneumo_LS @CHUdeLyon
Professor of Pulmonology @UnivLyon1
Scientific head @URCOT_lyon & @IFCTlung
#liquidbiopsy~#screening~????